Home » Drug Information » Recently Approved Drugs » 1997
Medical Areas: Endocrinology | Musculoskeletal | Obstetrics/Gynecology
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Barr Laboratories
Approval Status: Approved October 1997
Treatment Area: post-menopausal osteoporosis
Estradiol Tablets, the generic equivalent of Bristol Myers
Squibb's Estrace, has been approved for marketing. Barr's
Estradiol will be available in .5, 1, and 2 mg strengths. Estradiol
is used to treat moderate to severe vasomotor symptoms associated
with menopause as well as for the prevention of osteoporosis.
